BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2339824)

  • 1. Effect of pentoxifylline on the flow of polymorphonuclear leukocytes through a model capillary.
    Armstrong M; Needham D; Hatchell DL; Nunn RS
    Angiology; 1990 Apr; 41(4):253-62. PubMed ID: 2339824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid deformation of "passive" polymorphonuclear leukocytes: the effects of pentoxifylline.
    Needham D; Armstrong M; Hatchell DL; Nunn RS
    J Cell Physiol; 1989 Sep; 140(3):549-57. PubMed ID: 2777892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity.
    Newton JA; Ashwood ER; Yang KD; Augustine NH; Hill HR
    J Cell Physiol; 1989 Sep; 140(3):427-31. PubMed ID: 2550471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pentoxifylline on microvascular blood flow velocity.
    Ohshima N; Sato M
    Angiology; 1981 Nov; 32(11):752-63. PubMed ID: 7325410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline inhibits granulocyte and platelet function, including granulocyte priming by platelet activating factor.
    Hammerschmidt DE; Kotasek D; McCarthy T; Huh PW; Freyburger G; Vercellotti GM
    J Lab Clin Med; 1988 Aug; 112(2):254-63. PubMed ID: 2840477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pentoxifylline on the phagocytic activity, cAMP levels, and superoxide anion production by monocytes and polymorphonuclear cells.
    Bessler H; Gilgal R; Djaldetti M; Zahavi I
    J Leukoc Biol; 1986 Dec; 40(6):747-54. PubMed ID: 3023514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentoxifylline enhancement of defective neutrophil function and host defense in neonatal mice.
    Krause PJ; Kristie J; Wang WP; Eisenfeld L; Herson VC; Maderazo EG; Jozaki K; Kreutzer DL
    Am J Pathol; 1987 Nov; 129(2):217-22. PubMed ID: 3674202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actin depolymerization and inhibition of capping induced by pentoxifylline in human lymphocytes and neutrophils.
    Rao KM; Crawford J; Currie MS; Cohen HJ
    J Cell Physiol; 1988 Dec; 137(3):577-82. PubMed ID: 2848043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline pretreatment decreases the pool of circulating activated neutrophils, in-vivo adhesion to endothelium, and improves survival from hemorrhagic shock.
    Barroso-Aranda J; Schmid-Schönbein GW
    Biorheology; 1990; 27(3-4):401-18. PubMed ID: 2261506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline modulation of plasma membrane functions in human polymorphonuclear leukocytes.
    Hand WL; Butera ML; King-Thompson NL; Hand DL
    Infect Immun; 1989 Nov; 57(11):3520-6. PubMed ID: 2553608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentoxifylline modulates deformability, F-actin content, and superoxide anion production of polymorphonuclear leukocytes from diabetic cats.
    Sonkin PL; Freedman SF; Needham D; Rao KM; Hatchell DL
    Exp Eye Res; 1992 Dec; 55(6):831-8. PubMed ID: 1336731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline decreases endotoxin-induced pulmonary neutrophil sequestration and extravascular protein accumulation in the dog.
    Welsh CH; Lien D; Worthen GS; Weil JV
    Am Rev Respir Dis; 1988 Nov; 138(5):1106-14. PubMed ID: 3059889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pentoxifylline on neutrophil behaviour: stimulation of movement without adhesion changes.
    Crocket KV; Lackie JM; Rogers AA
    Biomed Pharmacother; 1988; 42(2):117-20. PubMed ID: 3167164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New aspects of the pharmacology of pentoxifylline].
    Lenoble Giovannangeli M
    J Mal Vasc; 1989; 14 Suppl A():35-41. PubMed ID: 2654314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of pentoxifylline on the flow properties of human blood.
    Ehrly AM
    Curr Med Res Opin; 1978; 5(8):608-13. PubMed ID: 710175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New pharmacological studies with pentoxifylline.
    Novick WJ; Sullivan G; Mandell G
    Biorheology; 1990; 27(3-4):449-54. PubMed ID: 2261511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pentoxifylline and metabolite on red blood cell deformability as measured by ektacytometry.
    Cummings DM; Ballas SK
    Angiology; 1990 Feb; 41(2):118-23. PubMed ID: 2306004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pentoxifylline and prostaglandin E1 on cold blood perfusion studied by red blood cell deformability.
    Sakai A; Kikuchi Y; Ohshima N; Hori M
    Angiology; 1987 Jul; 38(7):514-9. PubMed ID: 3619124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method of measuring red cell deformability and the effects of pentoxifylline.
    Isogai Y; Mochizuki K; Ashikaga M
    Curr Med Res Opin; 1981; 7(6):352-8. PubMed ID: 7238085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARDS, neutrophils, and pentoxifylline.
    Mandell GL
    Am Rev Respir Dis; 1988 Nov; 138(5):1103-5. PubMed ID: 3059888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.